加载中
NASDAQFinancial ServicesShell Companies
最新数据
US$12.11
−US$0.01 · -0.08%
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
前收盘价
US$12.11
−US$0.01 · -0.08%
盘后
US$12.35
+US$0.24 · +1.98%
10月9日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
日内区间
当前US$12.11
52周区间
当前US$12.11
盘中时间采用ET。市场数据可能有所延迟。
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
日内区间
当前US$12.11
52周区间
当前US$12.11
近期已公布业绩
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
